Loading...
Please wait, while we are loading the content...
A Phase Ib Dose-Escalation Study of LCL161 Plus Oral Topotecan for Patients With Relapsed/Refractory Small Cell Lung Cancer and Select Gynecologic Malignancies.
| Content Provider | Europe PMC |
|---|---|
| Author | Johnson, Melissa L Patel, Manish R Aljumaily, Raid Jones, Suzanne F Burris, III, Howard A Spigel, David R |
| Copyright Year | 2023 |
| Page Count | 8 |
| ISSN | 10837159 |
| Journal | The Oncologist |
| Volume Number | 28 |
| PubMed Central reference number | PMC10322128 |
| Issue Number | 7 |
| PubMed reference number | 37129455 |
| e-ISSN | 1549490X |
| DOI | 10.1093/oncolo/oyad029 |
| Language | English |
| Publisher | Oxford University Press |
| Publisher Date | 2023-07-01 |
| Publisher Place | US |
| Access Restriction | Open |
| Rights License | This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com. © The Author(s) 2023. Published by Oxford University Press. |
| Subject Keyword | small cell lung cancer gynecologic malignancies topotecan relapsed/refractory disease Smac mimetic |
| Content Type | Text |
| Resource Type | Article |
| Subject | Cancer Research Oncology |